Metraipolis › archive › dc_c02dc6bc9104

Formulation and Optimization of Sustained-Release Diclofenac Microspheres for Orally Disintegrating Tablets — Europe PMC PMID:41132706

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41132706
DOI
10.1155/ijbm/5552692
License (as archived)
solo-consultazione
Archived
2026-11-09T07:34:49.830Z
SHA-256 of the archived text
4f558dd78376e0f4046adbe96d08486ccd7c8fb5a328888a400c127345200dd5
Stable URL of this page
https://metraipolis.com/documento/dc_c02dc6bc9104

How to cite

Formulation and Optimization of Sustained-Release Diclofenac Microspheres for Orally Disintegrating Tablets — Europe PMC PMID:41132706 — Europe PMC (en), https://europepmc.org/article/MED/41132706 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c02dc6bc9104 (Metraipolis archive dc_c02dc6bc9104, sha256 4f558dd78376e0f4046adbe96d08486ccd7c8fb5a328888a400c127345200dd5)
BibTeX
@misc{dcc02dc6bc9104,
  title = {Formulation and Optimization of Sustained-Release Diclofenac Microspheres for Orally Disintegrating Tablets — Europe PMC PMID:41132706},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41132706},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c02dc6bc9104; sha256 4f558dd78376e0f4046adbe96d08486ccd7c8fb5a328888a400c127345200dd5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41132706. Agents can read the archived copy with the MCP tool read_document.